20:48 EDT Cathie Wood’s ARK Investment buys 294K shares of Crispr Therapeutics (CRSP) today
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CRSP:
- Cathie Wood Doubles Down on Nvidia Stock (NVDA) Ahead of Q1 Earnings
- Cathie Wood’s ARK Investment buys 262K shares of Crispr Therapeutics today
- Crispr Therapeutics AG: Promising Partnership with Sirius Therapeutics Amidst Clinical and Market Uncertainties Warrants Hold Rating
- Crispr Therapeutics call volume above normal and directionally bullish
- Strategic Growth and De-risking: Gil Blum’s Buy Rating on Crispr Therapeutics AG